Latest filing published 29 May 2009 for Lineage Cell Therapeutics, Inc., €5,729.
Insider track record
No signal scores available.
Hal Sternberg: trading record in brief
This profile gathers the share dealings of Hal Sternberg in Lineage Cell Therapeutics, Inc. Over a trading history stretching from 28 May 2009 to 29 May 2009, the count stands at 11 filings.
Every open-market trade on record is a sale: 9 sales worth €85k. Besides market trades, the filings include 2 option exercises.
The latest filing, published on 29 May 2009, reports an option exercise of €7,064 in Lineage Cell Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Hal Sternberg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,928 shares@ US$2.77Common Shares, no par valueSEC:0001209191-09-029693:1
- 5,000 shares@ US$2.80Common Shares, no par valueSEC:0001209191-09-029693:2
- 4,700 shares@ US$2.75Common Shares, no par valueSEC:0001209191-09-029693:3
- 1,000 shares@ US$2.71Common Shares, no par valueSEC:0001209191-09-029693:4
- 2,600 shares@ US$2.65Common Shares, no par valueSEC:0001209191-09-029693:5
- 1,000 shares@ US$2.61Common Shares, no par valueSEC:0001209191-09-029693:6
- 18,000 shares@ US$2.64Common Shares, no par valueSEC:0001209191-09-029693:7
- 2,000 shares@ US$2.60Common Shares, no par valueSEC:0001209191-09-029693:8
- 7,772 shares@ US$2.55Common Shares, no par valueSEC:0001209191-09-029693:9
9 of 9 declarations